S2 Genomics Raises Series A Round Led by BroadOak Capital Partners and RCT
Funding will accelerate commercialization of the Singulator platform which enables single cell or nuclei suspensions from solid tissues January 23, 2024 07:06 AM Eastern Standard Time LIVERMORE, Calif.–(BUSINESS WIRE)–S2 Genomics, the leading manufacturer of tissue…